JUL 1, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Azelastine Hydrochloride AND Fluticasone Propionate (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling for an established nasal spray combination; documents a regulatory action rather than new clinical evidence.
Reported
Approval date2026-07-01
Azelastine hydrochloride dose0.137 mg/spray
Fluticasone propionate dose0.05 mg/spray